The impact of neuraminidase on apoptosis in cultures of blood lymphocytes isolated from rats bearing Morris hepatoma

Cellular and Molecular Biology Letters

Volumn 9, Issue 2, 2004, Pages 389-399

  Ga̧siorowski, Kazimierz ^a   Steciwko, Andrzej ^a   Grata Borkowska, Urszula ^a   Drobnik, Jarosław ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Lymphocyte Apoptosis; Morris Hepatoma; Neuraminidase; Rats

Indexed keywords

SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME MECHANISM; LYMPHOCYTE; LYMPHOCYTE COUNT; MORRIS HEPATOMA; NONHUMAN; RAT;

ANIMALIA;

EID: 18244422095     PISSN: 14258153     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Gilboa, E. How tumors escape immune destruction and what we can do about it. Cancer Immunol. Immunother. 48 (1999) 382-385.
2. Kiessling, R., Wasserman, K., Horiguchi, S., Kono, K., Sjoberg, J., Pisa, P. and Petersson M. Tumor-induced immune dysfunction. Cancer Immunol. Immunother. 48 (1999) 353-362.
3. Pawelec, G. Tumour escape from immune response: the last hurdle for successful therapy of cancer? Cancer Immunol. Immunother. 48 (1999) 343-345.
4. thor Straten, P., Becker, J.C., Guldberg, P. and Zeuthen J. In situ T cells in melanoma. Cancer Immunol. Immunother. 48 (1999) 386-395.
5. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L.E. and Tschopp, J. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274 (1996) 1363.
6. Terheyden, P., Siedel, C., Merkel, A., Kampgen, E., Brocker, E.BV. and Becker, J.C. Predominant expression of Fas (Apo-1/CD95) ligand in metastatic melanoma revealed by longitudinal analysis. J. Invest. Dermatol. 112 (1999) 899-902.
7. Whiteside, T.L. Signaling defects in T lymphocytes of patients with malignancy. Cancer Immunol. Immunother. 48 (1999) 346-352.
8. Fredman, P. Glycosphingolipid tumor antigens. Adv. Lipid Res. 25 (1993) 13-34.
9. Ladisch, S., Hasegawa, A., Li, R. and Kiso, M. Immunosuppressive activity of chemically synthesized gangliosides. Biochemistry 34 (1995) 1197-1202.
10. Uzzo, R., Rayman, P., Kolenko, V., Clark, P.E., Cathart, M.K., Bloom, T., Noviock, A.C., Bukowski, R.M., Hamilton, T. and Finke, J.H. Renal cell carcinoma-derived gangliosides suppress nuclear factor κB activation in T cells. J. Clin Invest. 104 (1999) 769-776.
11. Ng, C.S., Novick, A.C., Tannenbaum, C.S., Bukowski, R.M. and Finke J.H. Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NKκB suppression. Urology 59 (2002) 9-14.
12. Uesugi, M., Koshino, T., Mitsugi, N. and Hiruma, T. Predictive value of serum immunosuppressive acidic protein for lung metastasis after amputation of murine osteosarcoma of the lower limb. Cancer Res. 155 (2000) 169-172.
13. Lögdberg, L. and Wester, L. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim. Biophys. Acta 1482 (2000) 284-297.
14. Shibata, Y., Tamura, K. and Ishida, N. In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in connection with its high level in tumor-bearing mice. Cancer Res. 43 (1983) 2889-2896.
15. Varki, A. Biologic role of oligosaccharides: all the theories are correct. Glycobiology 3 (1993) 97-130.
16. Hajela, K., Kayestha, R. and Kumar, P.G. Carbohydrate induced modulation of cell membrane. 1. Interaction of sialic acid with peripheral blood lymphocytes: a spin label study. FEBS Lett. 354 (1994) 217-219.
17. Hakomori, S. New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy. J. Exp. Med. 168 (1992) 211-222.
18. Satoh, M., Handa K. and Saito S. Disialosyl galactosyl-globoside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential. Cancer Res. 56 (1996) 1932-1938.
19. Ladisch, S., Becker, H. and Ulsh L. Immunosuppression by human ganglisides. I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochim. Biophys. Acta 1125 (1992) 180-188.
20. Grayson, G. and Ladisch S. Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK cell activity. Cell Immunol. 139 (1992) 18-29.
21. Paulson, J.C. Glycoproteins: what are the sugar chains for? Trends Biochem. Sci. 14 (1989) 272-276.
22. Zakharova, I.O. and Avrova, N.F. The effect of cold stress on ganglioside fatty acid composition and ganglioside-bound sialic acid content of rat brain subcellular fractions. J. Thermal Biol. 26 (2001) 215-222.
23. Senn, H.J., Ortyh, M., Fitzke, E., Stehle, T., Haussinger, D., Wieland, H. and Gerok, W. Biosynthesis and excretion of gangliosides by the isolated perfused rat liver. Eur. J. Biochem. (1992) 205 809-814.
24. Millar, J.S. The sialylation of plasma lipoproteins. Atherosclerosis 154 (2001) 1-13.
25. Sillanaukee, P., Ponnio, M. and Jaaskelainen, I.P. Occurrence of sialic acids in healthy humans and different disorders. Eur. J. Clin. Invest. 29 (1999) 413-425.
26. Saito, M. and Sugiyama, K. Expression of c-series of gangliosides in rat hepatocytes and liver tissues. Biochim. Biophys. Acta 1472 (1999) 617-624.
27. Qian, S., Wang, Z., Lee, Y., Chiang, Y., Bonham, C., Fung, J. and Lu L. Hepatocyte-induced apoptosis of activated T cells, a mechanism of liver transplantant tolerance, is related to the expression of ICAM-1 and hepatic lectin. Transplantation Proc. 33 (2001) 226-227.
28. Braun, J.R., Willnow, T.E., Ishibashi, S., Ashwell, G. and Herz J. The major subunit of the asialoglycoprotein receptor is expressed on the hepatocellular surface in mice lacking the minor receptor subunit. J. Biol. Chem. 271 (1996) 21160-21166.
29. Qian, S., Lu, L., Fu, F., Li, W., Starzl, T.E., Fung, J.J. and Thomson A.W. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implication for tolerance induction. J. Immunol. 158 (1997) 4654-4661.
30. Lee, Y.C., Lu, L., Fu, F., Li, A., Thomson, A.W., Fung, J.J. and Qian, S. Hepatocyte and liver nonparenchymal cells induce apoptosis in activated T cells. Transplantation Proc. 31 (1999) 784-785.
31. Taylor, G. Sialidases: structures, biological significance and therapeutic potential. Curr. Opin. Struct. Biol. 6 (1996) 830-837.
32. Barg, E., Ga̧siorowski, K., Brokos, B., Świȩdrych, A. and Skórkowska, K. A high frequency of apoptosis was found in cultures of lymphocytes isolated from the venous blood of children born with a low birth weight. Cell. Mol. Biol. Lett. 9 (2004) 135-143.
33. Pagliara, P., Chionna, A., Panzarini, E., De Luca, A., Caforion, S., Serra G., Abbro, L. and Dini, L. Lymphocyte apoptosis: young versus aged and humans versus rats. Tissue Cell 35 (2003) 29-36.
34. Gulbnins, E. Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol. Res. 47 (2003) 393-399.
35. Kim, S.H., Kim, S.C., Kho, Y.J., Kwak, S.W., Lee, H.G., You, S.K., Woo, J.H. and Choi, Y.J. C2-ceramide as a cell death inducer in HC11 mouse mammary epithelial cells. Cancer Lett. 203 (2004) 191-197.
36. Maccioni, H.J., Daniotti, J.L. and Martina, J.A. Organisation of ganglioside synthesis in the Golgi apparatus. Biochim Biophys. Acta 1437 (1999) 101-118.
37. Kong, Y., Li, R. and Ladisch S. Natural forms of shed tumor gangliosides. Biochim. Biophys. Acta 1394 (1998) 43-56.
38. Malisan, F. and Testi, R. GD3 in cellular ageing and apoptosis. Exp. Gerontol. 37 (2002) 1273-1282.
39. Scorrano, L., Petronilli, P., DiLisa, F. and Bernardi P. Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J. Biol. Chem. 274 (1999) 22581-22585.
40. Garcia-Ruiz, C., Colell, A., Paris, R. and Fernandez-Checa, J.C. Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release and caspase activity. FASEB J. 14 (2000) 847-858.
41. Ravagnan, L., Roumier, T. and Kroemer G. Mitochondria, the killer organelles and their weapons. J. Cell Physiol. 192 (2002) 131-137.
42. Collel, A., Garcia-Ruiz, C., Roman, J., Ballesta, A. and Fernandez-Checa, J.C. Ganglioside GD3 enhances apoptosis by suppressing the nulear factor-kappaB-dependent survival pathway. FASEB J. 15 (2001) 1068-1070.
43. Fernandez-Checa, J.C. Redox regulation and signaling lipids in mitochondrial apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 471-479.
44. Taki, T., Ishikawa, D., Ogura, M., Nakajima, M and Handa, S. Ganglioside CD 1 alpha functions in the adhesion of metastatic tumor cells to endothelial cells of the targert tissue. Cancer Res. 57 (1997) 1882-1888.
45. MacKallip, R., Li, R. and Ladisch, S. Tumor gangliosides inhibit the tumor-specific immune responses in vivo. J. Immunol. 163 (1999) 3718-3726.
46. Kudo, D., Rayman, P., Horton, C., Cathart, M.K., Bukowski, R.M., Thornton, M., Tannenbaum, C. and Finke, J.H. Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumour-induced apoptosis of T cells. Cancer Res. 63 (2003) 1676-1683.
47. Weiss, M., Hettmer, S., Smith, P. and Ladisch, S. Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase. Cancer Res. 63 (2003) 3654-3658.
48. Deng, W., Li, R. and Ladisch, S. Influence of cellular ganglioside depletion on tumor formation. J. Nat. Cancer Inst. 92 (2000) 912-917.
49. Malykh, Y.N., Schauer, R. and Shaw, L. N-glycolylneuraminic acid in human tumours. Biochimie 83 (2001) 623-634.
50. Lin, S., Kemmner, W., Grigull, S. and Schlag, P.M. Cell surface α2,6-sialynation affects adhesion of breast carcinoma cells. Exp. Cell Res. 276 (2002) 101-110.
51. Crocker, P.R. and Varki, A. Siglecs, sialic acids and innate immunity. Trends Immunol. 22 (2001) 337-342.